NCT03033316 A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT03033199 Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT03031730 Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma Status TERMINATED Phase PHASE1
NCT03030261 Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03029234 Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT03028012 TPI Medication Comparison - Ketorolac, Lidocaine, or Dexamethasone Status TERMINATED Phase PHASE4
NCT03023878 Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE2
NCT03023527 Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma Status TERMINATED Phase PHASE1
NCT03021772 Neostigmine Versus Dexamethasone as Adjuvants to Lidocaine During Intravenous Local Anesthesia Status COMPLETED Phase PHASE2/PHASE3
NCT03020030 Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03017391 Treatment Algorithm for Nausea and Vomiting in the Palliative Phase Status UNKNOWN Phase PHASE4
NCT03015792 Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant Status TERMINATED Phase PHASE1
NCT03012880 Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE2
NCT03011905 Rebound Pain After Operations for Distal Radius Fractures With a Volar Plate in Brachial Plexus Block Status COMPLETED Phase PHASE3
NCT03010202 The PROLONG Trial - Rituximab Maintenance Therapy in ITP Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03007147 Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03005496 The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β Status COMPLETED Phase PHASE4
NCT03004287 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03000660 Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis Status TERMINATED Phase PHASE1